NRG
GMED icon

Nemes Rush Group’s Globus Medical GMED Stock Holding History

Nemes Rush Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16K Hold
40
– – ﹤0.01% 726
2026
Q1 		$3.45K Buy
40
+16
+67% +$1.44K ﹤0.01% 676
2025
Q4 		$2.1K Buy
24
+4
+20% +$304 ﹤0.01% 727
2025
Q3 		$1.15K Hold
20
– – ﹤0.01% 627
2025
Q2 		$1.18K Hold
20
– – ﹤0.01% 641
2025
Q1 		$1.46K Hold
20
– – ﹤0.01% 626
2024
Q4 		$1.65K Buy
20
+15
+300% +$1.18K ﹤0.01% 631
2024
Q3 		$268 Sell
5
-15
-75% -$1.06K ﹤0.01% 586
2024
Q2 		$1.37K Buy
20
+15
+300% +$896 ﹤0.01% 538
2024
Q1 		$269 Buy
+5
New +$269 ﹤0.01% 647

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Nemes Rush Group's GMED Position: Q2 2026 in Review

Nemes Rush Group held its Globus Medical (GMED) position steady in Q2 2026 at 40 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #726.

Nemes Rush Group first reported a position in GMED in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.45K in Q1 2026. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Nemes Rush Group held 40 shares of Globus Medical worth $3.16K as of Q2 2026.
  • Nemes Rush Group left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up ﹤0.01% of Nemes Rush Group's portfolio in Q2 2026, its #726 holding.
  • Nemes Rush Group first reported a position in Globus Medical in Q1 2024 and has held it in 10 quarters since.
  • Nemes Rush Group's Globus Medical position peaked at $3.45K in Q1 2026.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.